Global Think-tank on Steatotic Liver Disease
Reframing liver disease. Advancing public health.
Connect
We bring together healthcare professionals, researchers, policymakers and people with lived experience to drive recognition, prevention, diagnosis, and equitable care of steatotic liver disease (SLD)—with a focus on metabolic dysfunction-associated SLD (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).
Discuss
We create space for inclusive dialogue on the systems, stories, and science shaping liver and metabolic health—focusing on patient engagement, health literacy, and the urgency of raising awareness across communities and care systems.
Discuss
We create space for inclusive dialogue on the systems, stories, and science shaping liver and metabolic health—focusing on patient engagement, health literacy, and the urgency of raising awareness across communities and care systems.